AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Silverwood Brands PLC

Director's Dealing Dec 31, 2025

10315_rns_2025-12-31_cbbb8e3b-c6a1-48a8-977d-57332d784637.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3047N

Silverwood Brands PLC

31 December 2025

31 December 2025

Silverwood Brands plc

("Silverwood" or the "Company"; together with its subsidiaries, the "Group)

Delay to Publication of Audited Results

Silverwood Brands plc (AQSE: SLWD), a holding company established to invest primarily in branded consumer businesses, announces that there has been a delay in completing the audit of the Group's results for the 18 month period ended 30 June 2025.

The delay arises from the additional time required to complete the audit of the Group's Japanese subsidiaries. This has been necessitated by the technically complex translation of subsidiary financial statements from Japanese Generally Accepted Accounting Principles ("Japanese GAAP") to International Financial Reporting Standards ("IFRS").

While the Group has previously audited and consolidated its Japanese subsidiaries, the Sonotas companies, the acquisition of Cosme Science during the period  introduced additional complexity to the current audit.

Temporary Suspension

Accordingly, as the Company will be unable to publish  audited results by 31 December 2025 as required by Rule 4.3 of the Aquis Growth Market Access Rulebook, trading in the Company's ordinary shares will be temporarily suspended with effect from 08.00 on Friday, 2 January 2026.

Unaudited Financial Information

For information purposes, limited unaudited financial information relating to the Group for the 18 month period ended 30 June 2025 is set out below.

This information has been extracted from the Company's draft report and accounts for the period ended 30 June 2025 and has not been audited. A further announcement will be released by the Company on completion of the audit and any material changes between the financial information set out below and the audited financial information will be disclosed in that announcement.

CONSOLIDATED STATEMENT OF FINANCIAL POSITION
30 June 2025 31 December 2023
Assets
Non-Current Assets
Property, Plant and Equipment 9,151,299 199,306
Intangible Assets 18,266,219 23,594,130
Other Non-Current Investments - 80
Trade and Other Receivables - -
27,417,518 23,793,516
Current Assets
Trade and Other Receivables 3,131,898 3,394,016
Inventories 2,493,049 1,727,768
Cash and Cash Equivalents 3,070,441 2,799,449
8,695,388 7,921,233
Total Assets 36,112,906 31,714,749
Liabilities
Non-Current Liabilities
Trade and Other Liabilities 878,334 1,996,367
Loans and Borrowings 7,588,104 1,264,449
Deferred Tax Liability 3,309,767 1,799,191
11,776,205 5,060,007
Current Liabilities
Trade and Other Liabilities 2,672,370 6,097,606
Loans and Borrowings 3,170,656 5,368,149
Provisions 398,970 286,282
6,241,996 11,752,037
Total Liabilities 18,018,201 16,812,044
Net Assets 18,094,705 14,902,705
Issued capital and reserves attributable to owners of the parent
Share Capital 4,250,018 3,250,018
Share Premium 27,195,826 22,795,826
Shares to be Issued 378,969 831,450
Reverse Takeover Reserve (2,014,193) (4,797,432)
Shared Based Payments Reserve 4,377,444 6,110,807
Foreign Exchange Reserve (508,956) (421,716)
Retained Earnings (15,533,691) (12,815,536)
18,145,417 14,953,417
Non-Controlling Interests (50,712) (50,712)
Total Equity 18,094,705 14,902,705
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
18 Months Ended 30 June 2025 As Restated: 12 Months Ended 31 December 2023
Revenue 23,912,606 11,094,983
Cost of Sales (10,177,871) (1,680,895)
Gross Profit 13,734,735 9,414,088
Other Operating Income 24,479 26,799
Selling and Distribution (1,723,467) (1,112,392)
Administrative Expenses (12,312,817) (8,756,008)
EBITDA (277,070) (427,513)
Depreciation (3,510,103) (1,308,793)
Exceptional Costs (4,159,939) (219,644)
Fair Value Movements 668,283 -
Acquisition costs, acquisition related contingent considerations and earn-outs 4,262,631 (3,842,615)
Profit/(Loss) from Operations (3,016,198) (5,798,565)
Finance Income 43,498 41,649
Finance Expense (1,111,406) (805,786)
Profit/(Loss) Before Tax (4,084,106) (6,562,702)
Tax Expense 57,499 471,528
Profit/(Loss) for the period (4,026,607) (6,091,174)
Items that are or may be reclassified subsequently to profit or loss.
Exchange Loss Arising on Translation on Foreign Operations (87,240) (421,716)
(87,240) (421,716)
Other Comprehensive Income for the Period, Net of Tax (87,240) (421,716)
Total Comprehensive Income (4,113,847) (6,512,890)
Loss for the period attributable to:
Owners of the Parent (4,026,607) (6,040,462)
Non-Controlling Interests - (50,712)
(4,026,607) (6,091,174)
Total comprehensive income for the period attributable to:
Owners of the Parent (4,113,847) (6,462,178)
Non-Controlling Interests - (50,712)
(4,113,847) (6,512,890)

ENDS

For more information, please contact:

Silverwood Brands plc
Andrew Gerrie [email protected]
Paul Hodgins
AlbR Capital Limited - Aquis Corporate Adviser +44 (0)20 7469 0930

About Silverwood Brands plc

Silverwood Brands  plc is a leader in the health and beauty industry, committed to developing and marketing high-quality products that meet the diverse needs of consumers worldwide. Through strategic acquisitions and organic growth, Silverwood Brands continues to enhance its portfolio and global reach, ensuring a strong position in the competitive health and beauty market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXGCBDDLUXDGUB

Talk to a Data Expert

Have a question? We'll get back to you promptly.